There are many ongoing advances in head and neck cancer in the context of radiation therapy delivery, clinical research on treatment options and advanced techniques in radiotherapy delivery. Failure to stay informed leads to lower quality of care by practicing clinicians.

This activity reviews the basic concepts of staging, overall treatment paradigm, radiation specific recommendations, radiation simulation, planning and treatment aspects, and literature regarding extremity and retroperitoneal soft tissue sarcomas.

The treatment approaches for lung cancer are rapidly evolving and include integration of new systemic therapies (e.g., immunotherapy and targeted therapies) into combined modality approaches for non-metastatic disease and ablative radiation therapy approaches for oligometastatic disease.

This activity focuses on recent and emerging research in radiation oncology for patients with brain and spine tumors. Special emphasis is placed on radiosurgery dose/fractionation selection, IDH inhibition in glioma and glioma contouring/targeting.

Modern treatment options such as radiotherapy dose intensification (EBRT boost, brachytherapy or Papillon technique) or additional chemotherapy in total neoadjuvant therapy for rectal cancers have been shown to improve rectal preservation rates better than ever before.

This activity provides a global overview of breast radiotherapy indications, approaches and techniques, informed by the latest clinical trials and relevant research.

The management of Hepatocellular Carcinoma (HCC) should be conducted in a multidisciplinary setting to offer individualized therapy. Most patients with HCC are not candidates for curative treatments because of tumor extent or underlying liver dysfunction.

There have been many advancements in terms of treatment and imaging modalities for patients with oligometastatic prostate cancer. Failure to understand these advancements in treatment options leads to lower quality of care delivered by clinicians treating prostate cancer patients.

Radiation and immunotherapies are commonly utilized sequentially or concurrently for the treatment of cancer patients, yet we are still developing our understanding of the optimal approaches for safely and effectively integrating these treatments.

MRI-guided Radiation Therapy (MRgRT), FLASH proton therapy, concurrent immunotherapy, and radiation therapy and SBRT for oligometastatic disease, are emerging technologies and approaches to optimize cancer care.